Already running a 110,000 square-foot manufacturing facility in Fort Collins, Tolmar Incorporated has announced plans to build an additional space twice that large some 17 miles to the southeast in Windsor.
The company, which has recorded annual revenues in excess of $95 million with a variety of pharmaceutical products, says the new Windsor site is needed to expand capacity in response to the demand for its product line.
That line includes injectable oncology and generic dermatology products, as well as its trademark Eligard, which is used to treat symptoms of prostate cancer.
Located at 701 Centre Avenue in Fort Collins, Tolmar was launched in 2006.
A timeline for the construction of the new Windsor facility has not yet been announced.
By Garry Boulard
Sign up for a free trial